Romain Chauvet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Romain Chauvet has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Géraud Forestier
Department of Neuroradiology, Clermont-Ferrand University Hospital, Clermont-Ferrand, France
4 shared publications Charbel Mounayer
3 shared publications- Maxime Baudouin
Université de Limoges, XLIM CNRS, UMR 7252, 87000 Limoges, France; CHU Limoges, Plateforme EMIS, Limoges, 87042, France; Sorbonne Université, Interventional Radiology Unit, AP-HP, Pitié-Salpêtrière Hospital, 75013 Paris, France
3 shared publications Alexis Belgacem
2 shared publicationsAymeric Rouchaud
Université de Limoges, XLIM CNRS, UMR 7252, 87000 Limoges, France; Department of Interventional Neuroradiology, Centre Hospitalier Universitaire de Limoges, 8700 Limoges, France
2 shared publications- Aymeric Rouchaud
Department of Diagnostic and Interventional Neuroradiology, Limoges University Hospital, Limoges, Nouvelle-Aquitaine, France
2 shared publications
Latest Publications
- 19 August 2026
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 53 (6)
Preclinical results of DERIVO® 2heal® vs DERIVO® 2 flow diverters in rabbit model under single antiplatelet therapy using HF-OCT
- 19 August 2026
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 53 (6)
Preclinical results of DERIVO® 2heal® vs DERIVO® 2 flow diverters in rabbit model under single antiplatelet therapy using HF-OCT
- Open Access
- 1 May 2026
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 107 (10) , 323-334
Optical coherence tomography in neurovascular intervention: Technical aspects and emerging directions
- 1 May 2026
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 107 (10) , 323-334
Open AccessOptical coherence tomography in neurovascular intervention: Technical aspects and emerging directions
- 20 November 2025
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 107 (3) , 91-102
Bioresorbable scaffolds in interventional radiology: Current concepts and future direction
- 20 November 2025
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 107 (3) , 91-102
Bioresorbable scaffolds in interventional radiology: Current concepts and future direction
- 18 March 2025
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 118 (6-7) , 345-347
New 2024 European Society of Cardiology guidelines on peripheral arterial and aortic diseases: Will they change our clinical practice in France?
- 18 March 2025
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 118 (6-7) , 345-347
New 2024 European Society of Cardiology guidelines on peripheral arterial and aortic diseases: Will they change our clinical practice in France?
- 1 May 2024
- Published by Hogrefe Publishing Group in Vasa
- Vol. 53 (3) , 211-216
Influenza vaccination coverage and determinants of vaccination in peripheral arterial disease patients
Summary: Background: In the latest American Heart Association guidelines, influenza vaccination is recommended for patients with peripheral arterial disease (PAD). The vaccination coverage in this specific population is currently unknown. This study aims to determine the adherence to influenza vaccination in a PAD population and identify associated determinants. Patients and methods. Hospitalized patients and outpatients with PAD from two university departments of vascular medicine were prospectively included. A questionnaire was administered to collect sociodemographic data, cardiovascular risk factors, influenza vaccination status, history of cardiovascular disease, and perception and knowledge about vaccination. Logistic regression was conducted to assess vaccination determinants. Results: Over a six-month period, 494 patients were included (median age 69.5, IQR [63–77], 78% male). Overall, 60.1% were either vaccinated or intended to be (Group 1). Vaccination was associated with age (odds-ratio [OR]=1.055, 95% confidence intervals [95%CI]: 1.035–1.075, p<0.0001), abdominal aorta aneurysm (OR=0.390, 95%CI: 0.229–0.664, p=0.001), chronic obstructive pulmonary disease (OR=0.545, 95%CI: 0.367–0.810, p=0.003), chronic renal disease (OR=0.630, 95%CI: 0.400–0.993, p=0.046), and valvulopathy (OR=2.444, 95%CI: 1.122–5.326, p=0.025). Only 25.3% received vaccination information mainly from their general practitioners. Among patients against vaccination, 59.9% considered themselves not concerned about potential influenza consequences on their PAD, and 37.6% did not intend to change their decision. Conclusions: This study highlights the low adherence to influenza vaccination in the PAD population of 2 university hospital centers. Vaccination is often related to age, and there is a need for adapted information regarding influenza consequences on cardiovascular disease overall, particularly on PAD. Addressing common information and advice about vaccination will be a challenge.
- 1 May 2024
- Published by Hogrefe Publishing Group in Vasa
- Vol. 53 (3) , 211-216
Influenza vaccination coverage and determinants of vaccination in peripheral arterial disease patients
Summary: Background: In the latest American Heart Association guidelines, influenza vaccination is recommended for patients with peripheral arterial disease (PAD). The vaccination coverage in this specific population is currently unknown. This study aims to determine the adherence to influenza vaccination in a PAD population and identify associated determinants. Patients and methods. Hospitalized patients and outpatients with PAD from two university departments of vascular medicine were prospectively included. A questionnaire was administered to collect sociodemographic data, cardiovascular risk factors, influenza vaccination status, history of cardiovascular disease, and perception and knowledge about vaccination. Logistic regression was conducted to assess vaccination determinants. Results: Over a six-month period, 494 patients were included (median age 69.5, IQR [63–77], 78% male). Overall, 60.1% were either vaccinated or intended to be (Group 1). Vaccination was associated with age (odds-ratio [OR]=1.055, 95% confidence intervals [95%CI]: 1.035–1.075, p<0.0001), abdominal aorta aneurysm (OR=0.390, 95%CI: 0.229–0.664, p=0.001), chronic obstructive pulmonary disease (OR=0.545, 95%CI: 0.367–0.810, p=0.003), chronic renal disease (OR=0.630, 95%CI: 0.400–0.993, p=0.046), and valvulopathy (OR=2.444, 95%CI: 1.122–5.326, p=0.025). Only 25.3% received vaccination information mainly from their general practitioners. Among patients against vaccination, 59.9% considered themselves not concerned about potential influenza consequences on their PAD, and 37.6% did not intend to change their decision. Conclusions: This study highlights the low adherence to influenza vaccination in the PAD population of 2 university hospital centers. Vaccination is often related to age, and there is a need for adapted information regarding influenza consequences on cardiovascular disease overall, particularly on PAD. Addressing common information and advice about vaccination will be a challenge.
- Open Access
- 25 August 2023
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 51 (3) , 236-241
Comparison of arterial wall integration of different flow diverters in rabbits: The CICAFLOW study
- 25 August 2023
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 51 (3) , 236-241
Open AccessComparison of arterial wall integration of different flow diverters in rabbits: The CICAFLOW study